0001415889-21-006216.txt : 20211223
0001415889-21-006216.hdr.sgml : 20211223
20211223201611
ACCESSION NUMBER: 0001415889-21-006216
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211221
FILED AS OF DATE: 20211223
DATE AS OF CHANGE: 20211223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schueren Robert Alan
CENTRAL INDEX KEY: 0001597341
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 211518654
MAIL ADDRESS:
STREET 1: 7400 PASEO PADRE PARKWAY
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-12232021_051259.xml
X0306
4
2021-12-21
0001604821
Natera, Inc.
NTRA
0001597341
Schueren Robert Alan
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
false
true
false
false
CHIEF OPERATING OFFICER
Common Stock
2021-12-21
4
M
0
5000
13.01
A
26517
D
Common Stock
2021-12-21
4
S
0
2707
92.5878
D
23810
D
Common Stock
2021-12-21
4
S
0
2293
93.4307
D
21517
D
Common Stock
2021-12-21
4
S
0
3671
92.5763
D
65612
I
Robert A Schueren & Deborah A Schueren Rev Trust
Common Stock
2021-12-21
4
S
0
3329
93.4252
D
62283
I
Robert A Schueren & Deborah A Schueren Rev Trust
Stock Option (right to buy)
13.01
2021-12-21
4
M
0
5000
0
D
2029-01-10
Common Stock
5000
48477
D
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.10 to $93.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.11 to $93.62 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.09 to $93.06 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Reporting Person is a trustee of the Robert A Schueren & Deborah A Schueren Rev Trust and has voting and dispositive power with respect to the reported shares. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.11 to $93.62 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vest over four years. 25% of the option shares vested and became exercisable on January 7, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
/s/ Tami Chen, Attorney-in-Fact
2021-12-23